Advances and challenges in the prevention and treatment of COVID-19
- PMID: 32714083
- PMCID: PMC7378666
- DOI: 10.7150/ijms.47836
Advances and challenges in the prevention and treatment of COVID-19
Abstract
Since the end of 2019, a new type of coronavirus pneumonia (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been spreading rapidly throughout the world. Previously, there were two outbreaks of severe coronavirus caused by different coronaviruses worldwide, namely Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). This article introduced the origin, virological characteristics and epidemiological overview of SARS-CoV-2, reviewed the currently known drugs that may prevent and treat coronavirus, explained the characteristics of the new coronavirus and provided novel information for the prevention and treatment of COVID-19.
Keywords: COVID-19; SARS-CoV-2; clinical treatment; drugs.; virological characteristics.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
References
-
- Coronavirus disease (COVID-19) outbreak. https://www.who.int/westernpacific/emergencies/covid-19.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous